Biomarkers for the prediction of blood pressure response to renal denervation: a long way to go.
نویسنده
چکیده
منابع مشابه
اثر سمپاتکتومی عروق کلیوی در بیماران با فشارخون مقاوم به درمان
Background: Sympathetic complex of over-activation kidneys is one of the main causes of primary hypertension (HTN). We aimed to assess the efficacy and safety of sympathectomy using 5Fr mariner catheter ablation on patients with refractory hypertension.Methods: In this prospective cohort study, patients who received three or more anti-hypertensive medications with 160mmHg systolic blood pressur...
متن کاملRenal denervation: the Irish experience.
I have read with great interest a paper authored by Dr. Kyvelou and colleagues published in this journal.1 This paper reported the Irish experience in renal denervation. In 24 patients with resistant hypertension who had completed 6-month follow-up after renal denervation, office systolic blood pressure was decreased by 6 mmHg (from 165 mmHg at baseline to 159 mmHg at 6 months, p=0.03), and 24-...
متن کاملLong term effects of kidney donation on blood pressure and kidney function of donors
Introduction: Kidney transplantation from a live donor has many advantages, but the donor should undergo a major surgery and accept potential morbidity and mortality. In this study, we evaluated the long term effects of nephrectomy on renal function and blood pressure of kidney donors. Methods: In this cross-sectional study, we assessed 195 kidney donors. The controls were 100 healthy individu...
متن کاملRenal denervation for hypertension: observations and predictions of a founder.
The 6-year anniversary of the first catheter-based renal denervation procedure for resistant hypertension has passed, and the 3-year follow-up results of the Symplicity HTN-1 are now published. At the 'end of the beginning', it is timely to reflect on the observations to-date for this revolutionary therapy, and to predict the next phase in its development and clinical application in hypertensio...
متن کاملDetermination Changes of Blood Biomarker Levels in Two Treatment status of Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients with Long-Term Schizophrenia
Background and objectives: Schizophrenia is a chronic psychiatric disorder, which reduces the patient quality of life. Despite the recommendation for treating this disorder with a minimum dose of medications, antipsychotic polypharmacy has been used experimentally that cause increasing the drug interactions. Aripiprazole has low risk of metabolic has recommended as a first line a treatment fo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Hypertension
دوره 63 5 شماره
صفحات -
تاریخ انتشار 2014